# OnCo record menin-plus-venetoclax-hma (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/menin-plus-venetoclax-hma/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "menin-plus-venetoclax-hma" ;
  schema:name "Menin inhibitor + venetoclax + azacitidine"@en ;
  schema:description "Combining the newest leukaemia drug class with the venetoclax backbone is producing remission rates in frontline NPM1 and KMT2A leukaemia that single agents never reached."@en ;
  schema:url <https://onco.cc/pairings/menin-plus-venetoclax-hma/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02993523> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:targets <https://onco.cc/targets/menin/>, <https://onco.cc/targets/npm1/>, <https://onco.cc/targets/kmt2a/> ;
  onco:drugs <https://onco.cc/drugs/ziftomenib/>, <https://onco.cc/drugs/revumenib/>, <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/> ;
  onco:pairs <https://onco.cc/drugs/ziftomenib/>, <https://onco.cc/drugs/venetoclax/> .